"BelVitunipharm" plans to produce diagnostic test systems for export to South Korea
JSC "BelVitunipharma" is not only diversifying its partner countries but also expanding its areas of activity. Recently, an agreement was signed with a major holding company specializing in the supply of diagnostic and protective agents against infectious diseases for medicine and veterinary medicine, which also implements comprehensive projects to provide foreign markets with innovative healthcare solutions. This holding company is the official representative of market leaders in the production of infectious disease diagnostic systems in Russia and the CIS countries.
The Republic of Korea is one of the key trade and economic partners of the Republic of Belarus in the Asian region. Within the framework of the signed agreement, it is planned to produce test systems for diagnosing various diseases and export them to South Korea, which will strengthen the company's position and develop cooperation in this region.